Asthma is a chronic inflammatory lung disease that narrows the airways. Asthma causes
recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Mostly,
the symptoms associated with asthma are short-lived and can be easily treated. Asthma
inhalers are medical devices which deliver medication into the body via the lungs, thereby,
treating asthma and chronic obstructive pulmonary disease. Increasing prevalence of
asthma is one of the major drivers for the market growth. According to the World Health
Organization in 2017, approximately 235 million people suffered from asthma. Moreover, it
was estimated that in 2015, the disease killed approximately 383 million patients around
the globe. Additionally, rising healthcare expenditures and increasing awareness fuel the
market growth. However, long treatment procedures and low per capita income followed by
lack of favorable reimbursement policies in the developing countries will restrain the market
growth during the forecast period.
The Global Asthma Devices Market is expected to grow at an approximate CAGR of 4.3%
during the forecast period.
Segmentation
The Global Asthma Devices Market is segmented on the basis of type, technology, and end
users.
On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The
inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers.
The metered-dose inhalers segment, by inhalers, is further categorized into standard
pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers,
metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented
into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.
On the basis of technology, the market is segmented into manually operated inhaler
devices, digitally operated inhaler devices, and others.
On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies,
and others.
Key players for global asthma devices market
GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia
Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter.
(U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1624 .
Regional Analysis
The Americas dominate the Global Asthma Devices Market owing to a well-developed
healthcare sector and huge patient population for asthma diseases. According to the
Centres for Disease Control and Prevention, in 2015, approximately, 7.8% of the total
population in the U.S. was identified for the presence of asthma. Moreover, changing
lifestyle and increasing healthcare expenditure fuels the market growth. Additionally, the
presence of global players like Merck & Co., Inc. and Baxter, and others boost market
growth during the forecast period.
Europe is the second largest asthma devices market owing to a well-developed healthcare
infrastructure and huge patient population. Moreover, government support for research &
development and rising healthcare expenditures fuel the market growth. According to a
study published in the Asthma Research and Practice journal in 2017, the yearly estimated
cost for all the asthmatics per patient is about USD 1,900. Additionally, the presence of the